Advertisement

Pharmacy

Despite the new "right-to-try" law, many drugmakers still want a relevant regulatory authority to review requests from patients with life-threatening illnesses who want access to experimental drugs, according to a recent Government Accountability Office report.

Advertisement
Advertisement